Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours
Title:
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours
Author:
Schöffski, Patrick Jones, Suzanne F. Dumez, Herlinde Infante, Jeffrey R. Van Mieghem, Elke Fowst, Camilla Gerletti, Paola Xu, Huiping Jakubczak, John L. English, Patricia A. Pierce, Kristen J. Burris, Howard A.